Objective: Hepatitis C virus (HCV) infection exerts diverse effects on atherogenesis. We investigated whether malnutrition inflammation score (MIS) is associated with the presence of coronary artery disease (CAD) in anti-HCV-positive hemodialysis (HD) patients. Subjects/Methods: Twenty-two anti-HCV-positive HD patients with CAD and 61 anti-HCV-positive HD patients without CAD (as controls) were included. Data were obtained from hospital records, patients were evaluated for risk factors for CAD. The same physician performed MIS evaluation. Results: MIS of anti-HCV-positive HD patients with CAD were significantly higher than patients without CAD (8.874.0 vs 6.572.6, P ¼ 0.02). In patients with CAD, basal (P ¼ 0.002) and peak C-reactive protein (P ¼ 0.03) and serum ferritin (P ¼ 0.01) concentrations were higher, serum albumin concentrations (P ¼ 0.003) were lower than those patients without CAD. MIS was positively correlated with age (r ¼ þ 0.359, P ¼ 0.001) and viral load (r ¼ þ 0.629, Po0.0001). In univariate logistic regression analysis, advanced age (odds ratios (OR) ¼ 1. 
Introduction
Cardiovascular disease is the major cause of death in uremia. There is evidence that chronic inflammation is associated with vascular pathology both in the general population and in dialysis, and the vascular system is the main target of the inflammatory process. Inflammation of coronary arteries could be involved in the development of coronary atherosclerosis and its related clinical syndromes. Specific risk factors for development of cardiovascular disease which are especially found in uremia, including oxidized low-density lipoprotein (LDL), free radicals, hyperhomocysteinemia, infections, acidosis and bioincompatibility may induce close interdependent links between chronic low-grade inflammation and atherosclerosis, and favor strongly an increased rate of atherosclerotic and thrombotic events including coronary artery disease (CAD), peripheral arterial disease and cerebrovascular diseases in end-stage renal disease patients (Santoro and Mancini, 2002) .
Protein energy malnutrition is a powerful predictor of death in end-stage renal disease patients (Beddhu et al., 2004) . Cardiovascular disease and protein energy malnutrition may be interrelated and protein energy malnutrition may directly contribute to a fatal outcome (Foley et al., 1996; Qureshi et al., 2002) . In the light of these findings, the malnutrition, inflammation and atherosclerosis hypothesis emerged which proposed that protein energy malnutrition, inflammation and atherosclerosis are interrelated (Yao et al., 2004) . For the combined assessment of malnutrition and inflammation in hemodialysis (HD) patients, a comprehensive scoring system called 'malnutrition inflammation score' (MIS), which is capable of risk stratifying in HD patients in a quantitative way for optimal management, was developed. MIS is strongly correlated with prospective hospitalizations and mortality, as well as measures of nutrition and inflammation (Kalantar-Zadeh et al., 2001) .
Infection with hepatitis C virus (HCV) is suggested to be atherogenic. However, liver injury, which is one clinical course of persistent chronic HCV infection, is associated with a decreased risk of atherosclerosis owing to a reduction of some risk factors for this disorder, such as serum total cholesterol concentration (Ishizaka et al., 2003) . HCV positivity is associated with significantly higher cardiovascular mortality in maintenance HD patients (Meyers et al., 2003; Kalantar-Zadeh et al., 2005) . In this study, we investigated whether MIS, which is related with atherosclerosis, is associated with CAD in anti-HCV-positive HD patients.
Materials and methods
Twenty-two anti-HCV-positive HD patients with CAD and 61 anti-HCV-positive HD patients without CAD (as controls) were included in the study. The study had a single-centered, cross-sectional design. Inclusion criteria were having anti-HCV positivity and undergoing maintenance HD for at least 12 months. One patient with hepatic failure, one patient with malignancy and an anticipated life expectancy of less than 6 months and one patient with chronic inflammatory condition (rheumatoid arthritis) were excluded. Demographic and laboratory data were obtained from hospital records and patients were evaluated for the presence of risk factors for CAD. Serum basal and peak C-reactive protein concentrations (the average of the three highest C-reactive protein measurements during the last 12 months) were determined. The same physician performed MIS evaluation during regular HD sessions of anti-HCV-positive HD patients with and without previously known CAD at the time of study enrollment.
CAD was defined as a history of acute coronary syndrome, myocardial infarction, angina pectoris or coronary revascularization procedure (coronary stent replacement and coronary artery by-pass graft surgery). Hypertension was defined as systolic blood pressure of 140 mm Hg or more, diastolic blood pressure of 90 mm Hg or more, or both. The diagnosis of type 2 diabetes mellitus was based on the data solely on fasting plasma glucose using a cutoff point of 7.0 mmol/l (regardless of the post-load plasma glucose concentrations) . Dyslipidemia was defined as serum total cholesterol levels 4200 mg/dl or serum LDL cholesterol levels 4130 mg/dl.
All HD patients were virtually anuric (24-h urine volume o200 ml/day) and were receiving 4 h HD thrice weekly with standard bicarbonate dialysis (sodium 138 mmol/l, bicarbonate 35 mmol/l, potassium 1.5 mmol/l, calcium 1.25 mmol/l and magnesium 1.8 mmol/l) by 1.1-1.7 m 2 hollow fiber dialyzer. Urea kinetic modeling was performed to assess the delivered equilibrated dose of dialysis. HD dose was evaluated using the following formula:
where spK t /V is a single-pool K t /V, R is the ratio of postdialysis to pre-dialysis serum urea nitrogen, t is time on dialysis in hours, UF is the amount of ultrafiltration in liters and W is post-dialysis body weight in kilograms. Serum anti-HCV was measured by the peptide synthesized microparticle enzyme immunoassay (MEIA-III, AxSYM HCV version 3.0, Abbott Laboratories, Paul-Ehrlich-Institut, Langen, Germany). The reverse transcription-PCR(RT-PCR) technique was used to assay HCV ribonucleoprotein (RNA). HCV RNA was quantified using the AcuGen RT-Amplisensor (Biotronics Tech. Corp., Lowell, MA, USA) assay, according to the manufacturer's instructions. The lower limit of the viral load assay was 500 copies/ml. Serum hemoglobin and hematocrit levels were measured in a Coulter STKS machine (Coulter Electronics Inc., FL, Fullerton, USA). Serum albumin levels were measured by quantitative colorimetric method (Stanbio Laboratory Inc., San Antonio, TX, USA). The turbidimetric latex agglutination method (BioSystems SA, Barcelona, Spain) was used to determine C-reactive protein levels and the upper limit of normal values set by the laboratory was 10 mg/l. A colorimetric method was used to measure serum calcium and phosphorus (Beckmann Cx-7 autoanalyzer, Beckman Instruments Inc., Diagnostic Systems Group, Brea, CA, USA). Serum levels of total cholesterol, high-density lipoprotein, LDL and triglyceride were measured by direct quantitative colorimetric method (Human Gesellchaft für Biochemica und Diagnostica mbH, Munich, Germany). Other biochemical parameters were measured using the standard laboratory methods.
Malnutrition inflammation score
The MIS consists of 10 components (weight change, dietary intake, gastrointestinal symptoms, functional capacity, comorbidity, subcutaneous fat, muscle wasting, BMI, serum albumin level, and total iron-binding capacity or serum transferrin level) that constitute four sections (nutritional history, physical examination, BMI and laboratory values). Each of the 10 components has four levels of severity that range from 0 (normal) to 3 (severely malnourished). The sum of the 10 components changes between 0 and 30. A higher score reflects a more severe degree of malnutrition and inflammation (Kalantar-Zadeh et al., 2001) .
Statistical analysis
Statistical analysis was performed using SPSS 10.0 for Windows (SPSS Inc., Evanston, IL, USA). The normality of the data was evaluated by the Kolmogorov-Smirnov test (Lilliefors modification). Data are shown as mean7s.d., median range and percentage (%). Results were considered statistically significant if two-tailed P is less than 0.05. Comparisons between two groups were assessed by means of t-test for normally distributed continuous variables and by Mann-Whitney U test for non-normally distributed continuous variables. For the analysis of categorical variables, w 2 and Fisher's Exact tests were used. Pearson's correlation coefficient r was used for the analysis of continuous variables. Univariate and multivariate stepwise backward logistic regression analyses were performed to assess the independent association of several variables including MIS with CAD in anti-HCV-positive HD patients. The effects were measured by odds ratios (ORs) and 95% confidence intervals (CIs) based on logistic regression models.
Results
The most common etiology for end-stage renal disease in anti-HCV-positive HD patients was glomerulonephritis (24.1%). The other etiologies for end-stage renal disease were vesicourethral reflux and pyelonephritis (16.9%), hypertension (9.6%), nephrolithiasis (9.6%), amyloidosis (7.2%), diabetes mellitus (4.8%), polycystic kidney disease (3.6%) and contrast nephropathy (1.2%). The etiology was unknown in 22.9% of the patients. Forty-two patients had HCV viral load 4500 copies/ml, whereas the viral load was negative in the remaining 41 patients. Thirty-four patients had received interferon therapy for a mean duration of 10.978.5 months. The prevalence of smoking, hypertension, diabetes mellitus and dyslipidemia were 44.6, 53.0, 12.0 and 28.9%, respectively. The patients with and without CAD were similar in terms of HCV viral loads. Histopathological results of liver biopsy were available in 31 (37.3%) patients. The percentages of patients who had received interferon treatment and the duration of the treatment were not different between the groups. The serologic profiles and interferon treatment characteristics of anti-HCV-positive patients with and without CAD are demonstrated in Table 1 . The prevalence of liver fibrosis in patients with and without CAD was similar (50.0 vs 60.0%, P ¼ 0.660).
The anti-HCV-positive HD patients with CAD were significantly older than those without CAD (Po0.0001). The prevalence of hypertension (P ¼ 0.028) and diabetes mellitus (P ¼ 0.019) were significantly higher in patients with CAD than those patients without CAD. Other demographic characteristics (gender, smoking, prevalence of dyslipidemia, dialysis vintage, HCV infection, hypertension and diabetes mellitus) were not different between anti-HCVpositive patients with and without CAD ( Table 2) . MISs of anti-HCV-positive HD patients with CAD were significantly higher than those patients without CAD (8.874.0 vs 6.572.6, P ¼ 0.02; Figure 1 ). In patients with CAD, basal C-reactive protein (P ¼ 0.002), peak C-reactive protein (P ¼ 0.03) and serum ferritin (P ¼ 0.01) concentrations were significantly higher, whereas serum albumin concentrations (P ¼ 0.003) were significantly lower than those patients without CAD. The serum calcium Â phosphorus products, total cholesterol, LDL cholesterol and intact parathyroid hormone concentrations were similar between the groups. The comparisons of spK t /V and laboratory parameters of anti-HCV-positive HD patients with and without CAD are shown in Table 3 .
Serum HCV RNA was positive in 42 patients and negative in 41 patients. When HCV RNA-positive and -negative HD patients were compared, albumin level was lower (P ¼ 0.031), and alanine aminotransferase (P ¼ 0.026) and iron levels were higher (P ¼ 0.009) in HCV RNA-positive patients than in negative patients. MISs of HCV RNA-positive HD patients were significantly higher than in HCV RNA-negative patients (8.172.4 vs 6.173.7, P ¼ 0.004). MIS was positively correlated with age (r ¼ þ 0.359, P ¼ 0.001) and HCV viral load (r ¼ þ 0.629, Po0.0001) in anti-HCV-positive HD patients. The correlations of MIS and other demographic and laboratory parameters are shown in Table 4 . analysis identified age (OR ¼ 1.090, CI: 1.007-1.179, P ¼ 0.033) and MIS as the factors associated with the presence of CAD (OR ¼ 1.232, CI: 1.004-1.511, P ¼ 0.04) in anti-HCVpositive HD patients (Table 5 ).
Discussion
Our results showed that anti-HCV-positive HD patients with CAD were older and had higher prevalence of hypertension and diabetes mellitus than patients without CAD. We demonstrated that in anti-HCV-positive HD patients with CAD, MIS, basal and peak C-reactive protein and serum ferritin concentrations were significantly higher, whereas serum albumin concentrations were significantly lower than those patients without CAD. MIS was higher in HCV RNApositive patients than in negative patients and was positively correlated with age and HCV viral load (copies/ml). In this study, chronic malnutrition/inflammation, as demonstrated by high MIS, was independently associated with the presence of CAD. Hepatitis C is an important cause of morbidity in HD patients and the prevalence in this population range from 6 to 38% (Zacks and Fried, 2001) . Ishizaka et al. (2002) showed that the presence of antibody against HCV was associated with an increased risk of carotid artery plaque in the general population. There are several possible mechanisms for the association between HCV infection and atherosclerosis. Chronic inflammation in HCV infection has been suggested to accelerate atherogenesis. Concentrations of soluble intercellular adhesion molecule-1 were reported to be higher in HCV patients than in control subjects. Anti-endothelial cell autoantibodies are commonly observed in HCV patients. Recently, using a molecular biology technique and animal models, some investigators have shown that HCV core protein can evoke oxidative stress. Taken together; these data suggest that HCV infection may play a role in vascular injury and the subsequent development of atherosclerosis. On the other hand, HCV infection and the consequent liver injury are associated with decreased serum total cholesterol concentration (Ishizaka et al., 2003) . The frequency of hypocholesterolemia in non-cirrhotic HCV-infected patients is five times higher than in the reference population. Serum cholesterol levels are also lower in patients with cirrhosis than in control groups. In patients with cirrhosis, the decrease in levels of LDL and total serum cholesterol is related to the progressive severity of the liver disease (Petit et al., 2003) .
In HD patients, MIS is strongly correlated with the measures of nutrition and inflammation as well as prospective hospitalizations and mortality (Kalantar-Zadeh et al., 2001) . In our study, we demonstrated that there is an ongoing and chronic process of malnutrition and inflammation in HCV-infected HD patients with CAD. Although presence of CAD seemed to be associated with risk factors such as advanced age, hypertension and diabetes mellitus in univariate analysis; multivariate analysis identified age and MIS as the factors independently associated with the presence of CAD. Low triglyceride, which also indicates malnutrition, was associated with CAD in univariate analysis. However, the association was not confirmed in multivariate analysis, probably due to our limited sample size. Since the MIS was positively correlated with the HCV viral load, but not with the duration of HCV infection, we suggest that the malnutrition-inflammation-atherogenesis process in HCV-infected individuals with end-stage renal disease is closely linked with the severity, rather than the duration of the HCV infection. Kalantar-Zadeh et al. (2005) have demonstrated that, after adjustment for surrogates of malnutrition-inflammation complex syndrome, HCV infection was associated with cardiovascular mortality in HD patients younger than 65 years of age. However, their database lacked systemic information on the history of cardiovascular comorbidity. In our study, we have evaluated the association of MIS and CAD in HCV-infected HD patients.
Our study has limitations. First, the number of the study sample is relatively small. Second, the study had a cross- sectional design. Lastly, the severity of liver injury could be assessed in a small proportion of our patients. Therefore, the exact severity of HCV infection in our study population could not be assessed. However, ours is a preliminary study and we note that the results presented here must be confirmed by future prospective studies in a larger number of patient population. We conclude that a high MIS may be associated with CAD in anti-HCV-positive HD patients.
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